Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiac iron concentration in relation to systemic iron status and disease severity in non‐ischaemic heart failure with reduced ejection fraction
Valentin G. Hirsch, Jörn Tongers, Julia Bode, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 11, pp. 2038-2046
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology
Ridha I.S. Alnuwaysir, Martijn F. Hoes, Dirk J. van Veldhuisen, et al.
Journal of Clinical Medicine (2021) Vol. 11, Iss. 1, pp. 125-125
Open Access | Times Cited: 104
Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy
Karen Sliwa, Peter van der Meer, Mark C. Petrie, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 4, pp. 527-540
Open Access | Times Cited: 62
Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia
Elisabeth Wyart, Myriam Y. Hsu, Roberta Sartori, et al.
EMBO Reports (2022) Vol. 23, Iss. 4
Open Access | Times Cited: 43
Empagliflozin effects on iron metabolism as a possible mechanism for improved clinical outcomes in non-diabetic patients with systolic heart failure
Christiane E. Angermann, Carlos G. Santos‐Gallego, Juan Antonio Requena-Ibáñez, et al.
Nature Cardiovascular Research (2023) Vol. 2, Iss. 11, pp. 1032-1043
Open Access | Times Cited: 33
Iron overload modulates follicular microenvironment via ROS/HIF-1α/FSHR signaling
Yaoqiu Wu, Yang Rong, Jie Lan, et al.
Free Radical Biology and Medicine (2023) Vol. 196, pp. 37-52
Closed Access | Times Cited: 28
Dysregulation of iron metabolism in cardiovascular diseases: From iron deficiency to iron overload
Yaguang Bi, Amir Ajoolabady, Laurie J. Demillard, et al.
Biochemical Pharmacology (2021) Vol. 190, pp. 114661-114661
Closed Access | Times Cited: 43
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM‐AHF trial
Marco Metra, Ewa A. Jankowska, Matteo Pagnesi, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 10, pp. 1928-1939
Open Access | Times Cited: 35
Critical re‐evaluation of the identification of iron deficiency states and effective iron repletion strategies in patients with chronic heart failure
Milton Packer, Stefan D. Anker, Javed Butler, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 6, pp. 1298-1312
Open Access | Times Cited: 7
The role and application of metal ions in maxillofacial bone defect
Xinyue Hu, Dongqi You, T Fei, et al.
Chemical Engineering Journal (2024) Vol. 493, pp. 152317-152317
Closed Access | Times Cited: 6
Identification of three mechanistic pathways for iron-deficient heart failure
Milton Packer, Stefan D. Anker, Javed Butler, et al.
European Heart Journal (2024) Vol. 45, Iss. 26, pp. 2281-2293
Open Access | Times Cited: 6
Anaemia predicts iron homoeostasis dysregulation and modulates the response to empagliflozin in heart failure with reduced ejection fraction: the EMPATROPISM-FE trial
Christiane E. Angermann, Susanne Sehner, Louisa M.S. Gerhardt, et al.
European Heart Journal (2024)
Open Access | Times Cited: 5
Cardiac energetics in patients with chronic heart failure and iron deficiency: an in‐vivo 31P magnetic resonance spectroscopy study
Francesco Papalia, Fadi Jouhra, George Amin‐Youssef, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 4, pp. 716-723
Open Access | Times Cited: 20
Pre-emptive iron supplementation prevents myocardial iron deficiency and attenuates adverse remodelling after myocardial infarction
Bomee Chung, Yong Wang, Marleen Thiel, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 10, pp. 1969-1980
Closed Access | Times Cited: 12
Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects
Qin Ru, Yusheng Li, Feng Zhang, et al.
Bone Research (2025) Vol. 13, Iss. 1
Open Access
A New Perspective on the Role of Alterations in Mitochondrial Proteins Involved in ATP Synthesis and Mobilization in Cardiomyopathies
Melissa Vázquez-Carrada, María Magdalena Vilchis‐Landeros, Héctor Vázquez‐Meza, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2768-2768
Open Access
Iron Deficiency Treatment in Heart Failure—Challenges and Therapeutic Solutions
Lucreția Anghel, Ciprian Dinu, Diana Pătraș, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 9, pp. 2934-2934
Open Access
Diagnosis and treatment of iron deficiency in chronic heart failure
Moritz Messner, Gerhard Pölzl, Christopher Adlbrecht, et al.
Wiener klinische Wochenschrift (2025) Vol. 137, Iss. S3, pp. 143-156
Open Access
Magnetic resonance imaging of organ iron before and after correction of iron deficiency in patients with heart failure
Christoph Gertler, Nadja Jauert, Patrick Freyhardt, et al.
ESC Heart Failure (2023) Vol. 10, Iss. 3, pp. 1847-1859
Open Access | Times Cited: 9
Iron deficiency in myocardial ischaemia: molecular mechanisms and therapeutic perspectives
Francesco Corradi, G Masini, Tonino Bucciarelli, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 14, pp. 2405-2420
Closed Access | Times Cited: 9
Prevalence and determinants of iron deficiency in cardiac amyloidosis
Antoine Jobbe Duval, Mélanie Bezard, Stéphane Moutereau, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 2, pp. 1314-1327
Open Access | Times Cited: 12
Relationship between iron deficiency and expression of genes involved in iron metabolism in human myocardium and skeletal muscle
Carin Corovic Cabrera, Christoffer Frisk, Ulrika Löfström, et al.
International Journal of Cardiology (2023) Vol. 379, pp. 82-88
Open Access | Times Cited: 6
Iron deficiency in young basketball players: Is a 100 μg/L ferritin cut‐off appropriate for iron supplementation?: Results of a randomized placebo‐controlled study
Emese Csulak, Titanilla Takács, Brigitta Babis, et al.
Clinical Cardiology (2023) Vol. 46, Iss. 9, pp. 1116-1123
Open Access | Times Cited: 5
Elevated SLC40A1 impairs cardiac function and exacerbates mitochondrial dysfunction, oxidative stress, and apoptosis in ischemic myocardia
Renqian Feng, Di Wang, Tiantian Li, et al.
International Journal of Biological Sciences (2023) Vol. 20, Iss. 2, pp. 414-432
Open Access | Times Cited: 5
Appraising the Causal Association between Systemic Iron Status and Heart Failure Risk: A Mendelian Randomisation Study
Xingchen Wang, Xizhi Wang, Yingchao Gong, et al.
Nutrients (2022) Vol. 14, Iss. 16, pp. 3258-3258
Open Access | Times Cited: 9
Iron Deficiency and Deranged Myocardial Energetics in Heart Failure
Michał Tkaczyszyn, Krzysztof Michał Górniak, Weronika Lis, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 24, pp. 17000-17000
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top